The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to ...

According to the Prescription Medicines Code of Practice Authority, Pfizer promoted unlicensed medicines and violated a total ...

Pfizer has picked up approval in the EU for ... cleared the dual inhibitor (JAK3 and TEC), given as a once-daily oral capsule, to treat people aged 12 and over with the condition, an autoimmune ...

Pfizer's disclosure Friday that it is ending global development and commercialization efforts for its hemophilia B treatment Beqvez brings an inauspicious ending to a gene therapy that got its ...

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.